ANGELA AMES: Open Payments
NPI 1427608710 · EVANSDALE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 22 payments from 11 companies in 2025. Trend: 2023 $819 · 2024 $1,245 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| PFIZER INC. | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Novo Nordisk Inc | 2 | $46 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $17 |
| Exact Sciences Corporation | 1 | $17 |
Products named: NURTEC ODT, Kerendia, BREZTRI, Ozempic, VRAYLAR, JOURNAVX, JARDIANCE, QULIPTA.
Industry payments across IA — which companies pay providers there.
